JUL 28, 2017 1:03 PM PDT

New Compound Targets Melanoma Division and Growth

WRITTEN BY: Xuan Pham

Broccoli, the polarizing cruciferous vegetable, is back in the headlines again. This time, researchers were inspired by a compound rich in this family of vegetables. When the engineered version was tested in a melanoma mouse model, it resulted in a 69 percent reduction in tumor size.

Image credit: Pixabay.com

The compound is currently known by a wildly complicated name: napthalamide-isoselenocyanate (NISC-6). The team got to this compound by modifying isoselenocyanate, which just so happens to be quite similar to another chemical found in vegetables, known as isothiocyanate. The natural version is rich in vegetables belonging to the cabbage family, which also includes cauliflower, kale, turnips, collards, Brussels sprouts, cabbage and radish.

NISC-6 has dual action: It blocks the Akt1 pathway, which promotes cell survival and growth, and the human topoisomerase IIα (topo IIα), an enzyme involved in changing the structure of DNA. It’s thought that both Akt1 and topo IIα contribute to melanoma growth.

"When a cell divides and grows, the DNA inside will become tangled much like the way a rope will if you take it and keep turning it in circles, it will get tangled. To untangle the rope you can either cut and join the rope or spend long time turning it in opposite direction to untangle it," explained Deepkamal Karelia, the study’s lead author. "The DNA has the same issue in our cells. To solve the problem, our bodies have a protein called topoisomerase, which cuts the DNA and joins it back to release the stress. What we show in this paper is this compound may be able to inhibit that activity of topo IIα protein -- the DNA is unable to unwind itself."

In lab experiments, NISC-6 caused human melanoma cells to go on a suicide mission. In mice with transplanted human melanomas, the tumors shrank by 69 percent. Furthermore, the team reports the compound has “excellent compliance” to Lipinski’s rule of five - a common pharmaceutical rule of thumb to evaluate if a drug is likely to be orally active, based on its molecular properties. While there are always exceptions to the rule, it’s been noted that compounds which adhere to the rule of five tend to have a higher chance of going to market.

The team has a long road ahead of them. They are still in the process of fully understanding how NISC-6 targets melanoma growth. But as to the link to broccoli, it’s important to remember that while NISC-6 has similarities to a chemical found in the vegetables, eating more of these veggies won’t necessarily do much if the tumor is already there.

"There are a lot of recommendations that, for example, broccoli can reduce your chances of getting cancer," said Dr. Arun Sharma, the study’s senior author. "Those are OK recommendations for prevention, but the compounds in the vegetables alone may not be potent enough to be used in a therapeutic environment."

Additional source: Penn State

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 20, 2021
Drug Discovery & Development
Blood Pressure Drugs Boost Survival in Colorectal Cancer
AUG 20, 2021
Blood Pressure Drugs Boost Survival in Colorectal Cancer
Common drugs used to regulate blood pressure may improve survival rates among patients with colorectal cancer, also know ...
AUG 26, 2021
Cancer
COVID-19 Vaccination Induces Strong Immunity in Cancer Patients
AUG 26, 2021
COVID-19 Vaccination Induces Strong Immunity in Cancer Patients
Cancer patients have a higher risk of developing severe symptoms from a COVID-19 infection.   Many cancer pati ...
SEP 27, 2021
Cell & Molecular Biology
Optical Imaging in Tissue with Near-Infrared Dyes
SEP 27, 2021
Optical Imaging in Tissue with Near-Infrared Dyes
Optical Imaging in Tissue with Near-Infrared Dyes Written By Christopher Pratt, PhD   Go Long to See Deeper Imaging ...
OCT 14, 2021
Immunology
'Bio-Betters' Form the Next Wave of Cancer Therapies
OCT 14, 2021
'Bio-Betters' Form the Next Wave of Cancer Therapies
  Antibodies are blood proteins with highly specialized functions: to recognize and eliminate bacteria, viruses, an ...
DEC 06, 2021
Cancer
Young Patients with Lymphoma Benefit from Chemotherapy Combination Treatment
DEC 06, 2021
Young Patients with Lymphoma Benefit from Chemotherapy Combination Treatment
The most common form of non-Hodgkin lymphoma is diffuse large B-cell lymphoma (DLBCL). DLBCL is a fast-growing cancer th ...
DEC 23, 2021
Cancer
Optimizing the Recovery Room Could Help Reduce the Recurrence of Bladder Cancer
DEC 23, 2021
Optimizing the Recovery Room Could Help Reduce the Recurrence of Bladder Cancer
It is estimated that nearly 84,000 people will be diagnosed with bladder cancer in the United States this year ...
Loading Comments...